- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Markets
Stocks
F&O
Mutual Funds
- More
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Jagsonpal Pharma Share Price
Jagsonpal Pharmaceuticals Ltd.
₹206
-1.28(-0.62%)
15th May 2026 | 3:28 PM
NSE : JAGSNPHARM
Open Free Demat Account
Jagsonpal Pharma Performance
Price Movement
₹206.00
₹205.42
₹210.00
↘ Today's Low↗ Today's High
1 Year Performance
₹206.00
₹155.00
₹301.65
↘ 52 Week Low↗ 52 Week High
Markets Today
High₹210.00
Low₹205.42
Open at₹206.00
Prev Close₹207.28
Volumes31.16 K
Avg Price₹207.68
Lower Circuit₹165.83
Upper Circuit₹248.73
Historical Performance
3M High₹225.12
3M Low₹157.55
1 Yr High₹301.65
1 Yr Low₹155.00
3 Yr High₹328.04
3 Yr Low₹109.44
5 Yr High₹328.04
5 Yr Low₹37.34
Jagsonpal Pharma Fundamentals
Market Cap
Above industry Median
1,384.50 Cr.
PE Ratio (TTM)
Above industry Median
32.10
Dividend Yield
Below industry Median
1.20
Net Profit TTM
22% decr over last year
43.08
Net Profit Growth
22% decr over last year
43.08
PEG Ratio
Negative PEG TTM
-1.40
ROE
33% decr over last year
15.59
Operating Revenue TTM
287.22
Operating Revenue Growth
6.9% incr over last year
Book Value
Above industry Median
5.20
MFI
MFI Overbought
79.02
RSI
RSI is mid-range
54.39
EPS (TTM)
-
Debt to Equity
-
Face Value
-
Operating Profit Margin Qtr.
-
Operating Profit Qtr.
-
Net Profit Qtr.
-
Operating Revenue Qtr.
-
PB Ratio
5.20
Jagsonpal Pharma Financials
*All values are in Rs. Cr
Loading chart...
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 64.20 | 72.94 | 74.46 | 75.61 | 58.56 |
| Operating Expense | 53.04 | 56.68 | 58.03 | 61.40 | 49.85 |
| Operating Profit | 11.16 | 16.27 | 16.43 | 14.21 | 8.71 |
| Depreciation | 2.32 | 2.39 | 2.39 | 2.35 | 2.30 |
| Interest | 0.25 | 0.26 | 0.26 | 0.25 | 0.26 |
| Tax | 2.99 | 3.57 | 4.24 | 3.64 | 2.12 |
| Net Profit | 8.76 | 10.95 | 12.57 | 10.80 | 6.58 |
Jagsonpal Pharma Technicals
Jagsonpal Pharmaceuticals Ltd. EMA & SMA
₹206.00
-1.28 (-0.62%)
↗ Bullish Moving Average
10
↘ Bearish Moving Average
6
Day EMA5 ₹208.7
Day EMA10 ₹208.8
Day EMA12 ₹208.3
Day EMA20 ₹205.4
Day EMA26 ₹203.1
Day EMA50 ₹196.7
Day EMA100 ₹195
Day EMA200 ₹200.7
Jagsonpal Pharma Support and Resistance
Resistance
First Resistance₹209.00
Second Resistance₹211.79
Third Resistance₹213.58
Support
First Support₹204.42
Second Support₹202.63
Third Support₹199.84
Technical Indicators
Day RSI54.39
Day MFI79.02
Day ADX40.97
Day Commodity Channel Index16.50
William-67.88
Day MACD5.15
Day MACD Signal Line6.11
Day ATR7.60
Day ROC125-2.44
Day ROC216.03
Jagsonpal Pharma Shareholding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 67.8 | 67.8 | 67.6 | 67.5 | 67.4 | 67.9 |
| FII | 2.1 | 2.1 | 2.2 | 2.1 | 2.1 | 2.4 |
| DII | 0 | 0 | 0 | 0.1 | 0.2 | 0.3 |
| Public | 30.1 | 30.1 | 30.1 | 30.2 | 30.3 | 29.4 |
Jagsonpal Pharma Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 33.11 K | 59.02 K | 56.10% |
| Week | 66.95 K | 1.24 L | 53.83% |
| 1 Month | 1.19 L | 2.26 L | 52.64% |
| 6 Month | 66.7 K | 1.42 L | 47.06% |
Jagsonpal Pharma SWOT Analysis
Strengths9
Weakness6
Opportunity1
Threats0
Companies with no Debt
Benjamin Graham Value Screen
Consistent high performing stocks over Five Years
Mid-range Performer (DVM)
PEG lower than Industry PEG
Effectively using its capital to generate profit - RoCE improving in last 2 years
Companies with Zero Promoter Pledge
RSI indicating price strength
Stocks Outperforming their Industry Price Change in the Quarter
Jagsonpal Pharma Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 12 Sep, 2025 | 2.5 | FINAL | 12 Sep, 2025 | Equity Share |
| 06 Sep, 2024 | 5 | FINAL | 06 Sep, 2024 | Equity Share |
| 21 Aug, 2023 | 5 | FINAL | 21 Aug, 2023 | Equity Share |
| 29 Oct, 2021 | 4 | INTERIM | 01 Nov, 2021 | Equity Share |
| 22 Sep, 2021 | 1 | FINAL | Equity Share | |
| 22 Sep, 2020 | 0.5 | FINAL | Equity Share | |
| 20 Sep, 2019 | 0.25 | FINAL | Equity Share | |
| 18 Sep, 2018 | 0.1 | FINAL | Equity Share | |
| 21 Sep, 2017 | 0.1 | FINAL | Equity Share | |
| 21 Sep, 2016 | 0.1 | FINAL | Equity Share |
Jagsonpal Pharma Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹485.35 | ₹6.65 | ₹130 | ₹13.40 | ₹99.60 | ₹154.25 |
| % Change | 0.99% | 1.06% | -1.49% | -1.76% | -0.41% | -0.53% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹282.74 | - | ₹377.86 | ₹207.10 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹15.30 | - | ₹6.98 | ₹26.05 |
| PE TTM | - | -1.60 | 32.80 | - | 75.30 | 20.60 |
| 1 Year Return | 22.77 | 559 | 2.72 | 46.7 | 7.37 | -24.79 |
| ROCE | 28.91 | -5.63 | - | - | 9.61 | 17.29 |
Similar Stocks
VENUSREM
Venus Remedies Ltd.
₹ 905.90
-3.39%
LASA
Lasa Supergenerics Ltd.
₹ 7.94
-0.13%
GUJTHEM
Gujarat Themis Biosyn Ltd.
₹ 368.00
-1.34%
MOREPENLAB
Morepen Laboratories Ltd.
₹ 41.91
-2.56%
MEDICAMEQ
Medicamen Biotech Ltd.
₹ 277.50
+2.10%
VINEETLAB
Vineet Laboratories Ltd.
₹ 34.00
-4.39%
AMRUTANJAN
Amrutanjan Health Care Ltd.
₹ 552.10
-3.79%
HIKAL
Hikal Ltd.
₹ 203.40
-2.57%
WANBURY
Wanbury Ltd.
₹ 254.25
-1.66%
MANGALAM
Mangalam Drugs and Organics Ltd.
₹ 29.95
-1.96%
IOLCP
IOL Chemicals and Pharmaceuticals Ltd.
₹ 105.85
-3.20%
HESTERBIO
Hester Biosciences Ltd.
₹ 1823.00
+4.76%
AAREYDRUGS
Aarey Drugs & Pharmaceuticals Ltd.
₹ 88.06
-3.55%
ALBERTDAVD
Albert David Ltd.
₹ 722.00
+2.57%
KOPRAN
Kopran Ltd.
₹ 155.50
-1.54%
ORTINGLOBE
Ortin Global Ltd.
₹ 14.55
-0.34%
KREBSBIO
Krebs Biochemicals & Industries Ltd.
₹ 56.10
-0.81%
BALPHARMA
Bal Pharma Ltd.
₹ 80.50
+1.96%
BAFNAPH
Bafna Pharmaceuticals Ltd.
₹ 135.30
-0.44%
RPGLIFE
RPG Life Sciences Ltd.
₹ 2277.20
-3.03%
INDOCO
Indoco Remedies Ltd.
₹ 225.00
-0.24%
AARTIDRUGS
Aarti Drugs Ltd.
₹ 367.00
+1.28%
NATCAPSUQ
Natural Capsules Ltd.
₹ 153.45
-1.53%
SMSPHARMA
SMS Pharmaceuticals Ltd.
₹ 401.70
+0.55%
FAQ's on JAGSNPHARM
What is the current share price of Jagsonpal Pharmaceuticals Ltd.?
As of 6 June 2025 at 10:01 AM, the share price for Jagsonpal Pharmaceuticals Ltd. is ₹ 206 on the NSE and ₹ 207.2 on the BSE. (Note: Prices are dynamic and update frequently during market hours).
What is the Market Capitalization of Jagsonpal Pharmaceuticals Ltd.?
Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Jagsonpal Pharmaceuticals Ltd. is approximately ₹ 1384.5 Cr.
What are the PE and PB ratios for Jagsonpal Pharmaceuticals Ltd.?
Based on recent data, the Price-to-Earnings (PE) ratio for Jagsonpal Pharmaceuticals Ltd. is 32.1, and the Price-to-Book (PB) ratio is 5.2.
What is the 52-Week High and Low for Jagsonpal Pharmaceuticals Ltd.?
Over the past 52 weeks, the highest price reached by Jagsonpal Pharmaceuticals Ltd. shares was ₹ 301.65, and the lowest price was ₹ 155.
What is the current dividend yield for Jagsonpal Pharmaceuticals Ltd.?
As of 6 June 2025, the dividend yield for Jagsonpal Pharmaceuticals Ltd. is 1.2%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.
Who are the major shareholders of Jagsonpal Pharmaceuticals Ltd.?
Significant shareholdings in Jagsonpal Pharmaceuticals Ltd. typically include entities such as:
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
- Promoter
- Public
- FII
- Other Institutions
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
Who are the peers of Jagsonpal Pharmaceuticals Ltd. in the Pharmaceuticals & Biotechnology sector?
In the Pharmaceuticals & Biotechnology sector, Jagsonpal Pharmaceuticals Ltd. is often compared with other major players such as
Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs and Corona Remedies for analysis and benchmarking.
What is the latest dividend information for Jagsonpal Pharmaceuticals Ltd.?
Jagsonpal Pharmaceuticals Ltd. last declared a FINAL dividend of ₹ 2.5 per share for the financial period ending 2025. The record date was set as 2025-09-12, and the payment was/is scheduled around 2025-09-12. For the most current dividend announcements, refer to official company filings.
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy